Abstract 24S-hydroxycholesterol (24OHC) and Tau are produced in neuronal cells and neurodegeneration leads to increased flux of both of them…
Abstract A 60-year-old female was treated for depression with the antidepressant paroxetine for 13 years. The patient had experienced clumsiness…
Abstract There are currently no disease-modifying treatments for progressive supranuclear palsy (PSP) or corticobasal degeneration (CBD), and no approved pharmacological…
Abstract 123I-ioflupane single photon emission computed tomography (SPECT) is a sensitive and well established imaging tool in Parkinson’s disease (PD)…
Abstract Background: Non-fluent agrammatic primary progressive aphasia (naPPA) is characterized by progressive non-fluent speech disorder and might be associated with…
Abstract Background: A certain number of mutations in the Microtubule-Associated Protein Tau (MAPT) gene have been identified in individuals with…
Abstract Myoclonus in corticobasal degeneration (CBD) has often been associated with severe and difficult to treat disabilities. Levetiracetam is a…
Abstract Background: Corticobasal degeneration (CBD) is a complex neurodegenerative disorder. Accurate diagnosis is increasingly important, with the advent of clinical…
Abstract Objective: Differentiating idiopathic Parkinson’s disease from atypical parkinsonian syndromes is challenging, especially in the early stages. We assessed whether…
Abstract Parkinson’s disease is a principal underlying disease of neuroleptic malignant syndrome (NMS) occurring in parkinsonian disorders, but NMS may…